Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
This study has been terminated.
Sponsor:
Stanford University
Collaborators:
University of Minnesota - Clinical and Translational Science Institute
University of Alabama at Birmingham
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00957931
First received: August 12, 2009
Last updated: December 20, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |